Cargando…

Unravelling the heterogeneity of soft tissue and bone sarcoma patients’ health-related quality of life: a systematic literature review with focus on tumour location

Patients with sarcoma experience many physical and psychological symptoms, adversely affecting their health-related quality of life (HRQoL). HRQoL assessment is challenging due to the diversity of the disease. This review aims to unravel the heterogeneity of HRQoL of patients with sarcoma with regar...

Descripción completa

Detalles Bibliográficos
Autores principales:	den Hollander, Dide, Van der Graaf, Winette T.A., Fiore, Marco, Kasper, Bernd, Singer, Susanne, Desar, Ingrid. M.E., Husson, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577059/ https://www.ncbi.nlm.nih.gov/pubmed/33082266 http://dx.doi.org/10.1136/esmoopen-2020-000914

Ejemplares similares

Unraveling the Heterogeneity of Sarcoma Survivors’ Health-Related Quality of Life Regarding Primary Sarcoma Location: Results from the SURVSARC Study
por: van Eck, Ilse, et al.
Publicado: (2020)

Quality of life and experiences of sarcoma trajectories (the QUEST study): protocol for an international observational cohort study on diagnostic pathways of sarcoma patients
por: Soomers, Vicky, et al.
Publicado: (2020)

‘I thought I had fibroids, and now I don’t’: a mixed method study on health-related quality of life in uterine sarcoma patients
por: den Hollander, Dide, et al.
Publicado: (2022)

Incorporating the Patient Voice in Sarcoma Research: How Can We Assess Health-Related Quality of Life in This Heterogeneous Group of Patients? A Study Protocol
por: den Hollander, Dide, et al.
Publicado: (2020)

The sarcoma diagnostic interval: a systematic review on length, contributing factors and patient outcomes
por: Soomers, Vicky, et al.
Publicado: (2020)

Health-related quality Of Life In patients with advanced Soft TIssue sarcomas treated with Chemotherapy (The HOLISTIC study): protocol for an international observational cohort study
por: Younger, Eugenie, et al.
Publicado: (2020)

Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin
por: Desar, Ingrid M E, et al.
Publicado: (2016)

Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first‐line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer‐Soft Tissue and Bone Sarcoma Group (EORTC‐STBSG)
por: Lindner, Lars H., et al.
Publicado: (2018)

Symptoms reported by gastrointestinal stromal tumour (GIST) patients on imatinib treatment: combining questionnaire and forum data
por: den Hollander, Dide, et al.
Publicado: (2022)

Health-Related Quality of Life Issues Experienced by Thoracic and Breast Sarcoma Patients: A Rare and Understudied Group
por: van Eck, Ilse, et al.
Publicado: (2021)

Systemic Treatment for Adults with Synovial Sarcoma
por: Desar, Ingrid M. E., et al.
Publicado: (2018)

Desmoid is not a sarcoma; reply to Sachdev et al.
por: van der Graaf, Winette T.A., et al.
Publicado: (2023)

Sample Bias in Web-Based Patient-Generated Health Data of Dutch Patients With Gastrointestinal Stromal Tumor: Survey Study
por: Dirkson, Anne, et al.
Publicado: (2022)

Imatinib, sunitinib and pazopanib: From flat‐fixed dosing towards a pharmacokinetically guided personalized dose
por: Westerdijk, Kim, et al.
Publicado: (2020)

Gastrointestinal Stromal Tumours (GIST) in Young Adult (18–40 Years) Patients: A Report from the Dutch GIST Registry
por: IJzerman, Nikki S., et al.
Publicado: (2020)

Prognostic Significance of Bone Metastasis in Soft Tissue Sarcoma Patients Receiving Palliative Systemic Therapy: An Explorative, Retrospective Pooled Analysis of the EORTC-Soft Tissue and Bone Sarcoma Group (STBSG) Database
por: Kantidakis, Georgios, et al.
Publicado: (2022)

Metastatic Soft Tissue Sarcomas in Adolescents and Young Adults: A Specialist Center Experience
por: Younger, Eugenie, et al.
Publicado: (2020)

The relationship between sunitinib exposure and both efficacy and toxicity in real‐world patients with renal cell carcinoma and gastrointestinal stromal tumour
por: Westerdijk, Kim, et al.
Publicado: (2020)

The route to diagnosis of sarcoma patients: Results from an interview study in the Netherlands and the United Kingdom
por: Soomers, Vicky L. M. N., et al.
Publicado: (2020)

Prognostic Factors in a Large Nationwide Cohort of Histologically Confirmed Primary and Secondary Angiosarcomas
por: Weidema, Marije E., et al.
Publicado: (2019)

Priorities and preferences of advanced soft tissue sarcoma patients starting palliative chemotherapy: baseline results from the HOLISTIC study
por: Younger, E., et al.
Publicado: (2021)

Age-related sarcoma patient experience: results from a national survey in England
por: Younger, Eugenie, et al.
Publicado: (2018)

The challenge of finding new therapeutic avenues in soft tissue sarcomas
por: Kasper, Bernd
Publicado: (2019)

Psychological and social challenges of patients with locally advanced and metastatic gastrointestinal stromal tumours (GIST) on long-term treatment with tyrosine kinase inhibitors: a qualitative study with patients and medical oncologists
por: van de Wal, Deborah, et al.
Publicado: (2023)

Health-Related Quality of Life and Side Effects in Gastrointestinal Stromal Tumor (GIST) Patients Treated with Tyrosine Kinase Inhibitors: A Systematic Review of the Literature
por: van de Wal, Deborah, et al.
Publicado: (2022)

Personalized Therapy of Sarcomas
por: Desar, Ingrid M. E., et al.
Publicado: (2023)

Immunotherapy in soft tissue and bone sarcoma: unraveling the barriers to effectiveness
por: Panagi, Myrofora, et al.
Publicado: (2022)

Adherence to Guidelines for Adult (Non-GIST) Soft Tissue Sarcoma in the Netherlands: A Plea for Dedicated Sarcoma Centers
por: Hoekstra, Harald J., et al.
Publicado: (2017)

New Systemic Therapy Options for Advanced Sarcomas
por: van der Graaf, Winette T. A., et al.
Publicado: (2012)

The Perceived Impact of Length of the Diagnostic Pathway Is Associated with Health-Related Quality of Life of Sarcoma Survivors: Results from the Dutch Nationwide SURVSARC Study
por: Soomers, Vicky L. M. N., et al.
Publicado: (2020)

Optimizing the dose in patients treated with imatinib as first line treatment for gastrointestinal stromal tumours: A cost‐effectiveness study
por: Zuidema, Sander, et al.
Publicado: (2019)

Survival and Cost-Effectiveness of Trabectedin Compared to Ifosfamide Monotherapy in Advanced Soft Tissue Sarcoma Patients
por: Verboom, Michiel C., et al.
Publicado: (2019)

Unraveling novel TF-miRNA regulatory crosstalk in metastasis of Soft Tissue Sarcoma
por: Samantarrai, Devyani, et al.
Publicado: (2015)

Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma
por: Planas‐Paz, Lara, et al.
Publicado: (2023)

Heterogeneity of Soft Tissue Sarcomas and Its Implications in Targeted Therapy
por: Du, Xin-Hui, et al.
Publicado: (2020)

Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data
por: Mohammadi, Mahmoud, et al.
Publicado: (2023)

Circulating tumour-derived DNA in metastatic soft tissue sarcoma
por: Eastley, Nicholas C., et al.
Publicado: (2018)

Non-gastrointestinal stromal tumours soft tissue sarcomas: an update
por: Matos, Gustavo Duarte Ramos, et al.
Publicado: (2019)

Targeting the FAK-Src Complex in Desmoplastic Small Round Cell Tumors, Ewing Sarcoma, and Rhabdomyosarcoma
por: van Erp, Anke E. M., et al.
Publicado: (2022)

Alveolar Soft Part Sarcoma of the Tongue: A Rare Tumor at an Unusual Location
por: Qureshi, Asim, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_35rqrdqsgt4isbbit6leifp365